This study aimed to describe the prevalence of comorbidities associated with chronic
obstructive pulmonary disease (COPD) and their relation with relevant outcomes. A …

Tobacco smoking is a major cause of chronic obstructive pulmonary disease (COPD) and
atherosclerotic cardiovascular disease (ASCVD). These diseases share common …

Rationale: In the phase III, 52-week ETHOS (Efficacy and Safety of Triple Therapy in
Obstructive Lung Disease) trial in chronic obstructive pulmonary disease (COPD) …

Background The association between chronic obstructive pulmonary disease exacerbations
and increased cardiovascular event risk has not been adequately studied in a heterogenous …

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death and is
associated with multiple medical and psychological comorbidities. Therefore, future …

Aim Prevalence of chronic obstructive pulmonary disease (COPD) in atrial fibrillation (AF)
patients is unclear, and its association with adverse outcomes is often overlooked. Our aim …

Mesenchymal cells are an essential cell type because of their role in tissue support, their
multilineage differentiation capacities and their potential clinical applications. They play a …

Background Chronic obstructive pulmonary disease (COPD) is the third most common
cause of death around the world. The affected patients suffer not only from impaired lung …

Patients with chronic obstructive pulmonary disease (COPD) are at increased risk of
cardiovascular disease (CVD) and concomitant disease leads to reduced quality of life …

Background Obstructive sleep apnea syndrome (OSAS) and chronic obstructive pulmonary
disease (COPD) are two chronic diseases that afflict many individuals worldwide with …